NPM1 mutant AML Archives

Danielle Garcia - April 27, 2020

Editorial Team - March 13, 2023

Danielle Garcia - February 27, 2023

Editorial Team - February 27, 2023

Editorial Team - February 23, 2023

Julie Rovner - February 21, 2023

Deep Bio’s Novel Study Results Reaffirm Its Global Presence March 14, 2023
USCAP 2023 is Deep Bio’s sixth consecutive year of presenting research abstracts(PRWeb March 14, 2023)Read the full story at https://www.prweb.com/releases/2023/03/prweb19209392.htm
Study Adds Support for Cxbladder Monitor Use in Cancer Surveillance March 14, 2023
Cancer diagnostics company Pacific Edge (NZX, ASX: PEB) welcomes the release of new research supporting the clinical utility of the company’s genomic biomarker test Cxbladder Monitor in the...(PRWeb March 14, 2023)Read the full story at https://www.prweb.com/releases/2023/3/prweb19220555.htm
RSNA: Huge Study Finds Tomosynthesis Better at Breast Cancer Detection March 14, 2023
In a study of over a million women, digital breast tomosynthesis (DBT) showed improved breast cancer screening outcomes over screening with standard digital mammography alone. The results of the study...(PRWeb March 14, 2023)Read the full story at https://www.prweb.com/releases/rsna_huge_study_finds_tomosynthesis_better_at_breast_cancer_detection/prweb19221463.htm

Tag: NPM1 mutant AML